Clinical Trials Directory

Trials / Completed

CompletedNCT00435110

Effects of PEEP and FIO2 in ALI and ARDS

Effects of PEEP and FiO2 in the Evaluation of Severity of ALI and ARDS

Status
Completed
Phase
Study type
Observational
Enrollment
178 (actual)
Sponsor
Instituto Canario de Investigacion Biomedica · Academic / Other
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

Current American-European Consensus Conference (AECC) definitions for ALI and ARDS are inadequate for inclusion into clinical trials due to the lack of standardization for measuring the oxygenation defect. We questioned whether an early assessment of oxygenation on specific ventilator settings would identify patients with established ARDS (persisting over 24h).

Detailed description

We designed this study to determine whether standard ventilator settings applied on the day ARDS is identified (Day 0) or 24 hours (Day 1) later: (1) would have an impact on the reclassification of patients into ALI or ARDS, and (2) would identify groups with different clinical outcomes. Our hypothesis was that the assessment of PaO2/FiO2 on standard ventilator settings 24 hours after patients originally met the AECC definition of ARDS would identify patients with established ARDS (persisting over 24 h) from others with different degrees of lung injury. If this hypothesis is supported, it would suggest that patients with a better outcome could have been preferentially entered into one group of previously conducted clinical trials, resulting in a viable therapy being proved useless or useless therapy proven viable.

Conditions

Interventions

TypeNameDescription
PROCEDUREstandard ventilatory settings
PROCEDUREPEEP and FiO2

Timeline

Start date
2004-05-01
Completion
2005-10-01
First posted
2007-02-14
Last updated
2018-10-11

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT00435110. Inclusion in this directory is not an endorsement.